The largest database of trusted experimental protocols

Glomax bioluminescent reader

Manufactured by Promega

The GloMax® bioluminescent reader is a versatile instrument designed to detect and quantify bioluminescent signals. It utilizes sensitive photodetectors to measure luminescent output from a variety of sample types, supporting applications such as reporter gene assays, cell-based assays, and ATP quantification.

Automatically generated - may contain errors

3 protocols using glomax bioluminescent reader

1

Measuring 3D Cell Viability of Panc-1 Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability of Panc-1 spheroids was measured using a 3D cell viability assay (Promega, Milan, Italy). Briefly, homogeneous spheroids were removed from the 96-well low-attachment culture plate and placed separately in single wells of a 96-well opaque culture plate (BD Falcon). CellTiter-Glo® 3D reagent was added to each well and the luminescence signal was read after 30 min with the GloMax® bioluminescent reader (Promega).
+ Open protocol
+ Expand
2

Lactic Dehydrogenase Release Assay for GBM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lactic dehydrogenase release was measured in the GBM culture supernatants using the LDH-GloTM Cytotoxicity Assay (Promega, cat n. J2380), according to the manufacturer’s instructions. Briefly, 1.5 × 105/well GBM cells were plated in six-well plates. At the following time points from radiation treatment (1 day, 7 days, 14 days, 21 days, and 28 days), cell supernatants diluted 1:25 in LDH storage buffer (200 mM Tris-HCl (pH 7.3), 10% Glycerol, 1% BSA in deionized water) were added to LDH detection reagent at 1:1 ratio and incubated at room temperature for 60 min. Luminescence was measured using the GloMax® bioluminescent reader (Promega). Percent LDH release (%), was calculated with the formula: LDH release (%) = [(experimental LDH release value) − (background value)]/[(LDH release value in 10% Triton X-100-treated samples) − (background value)] × 100. Lactic dehydrogenase release was normalized on the total amount of protein (µg).
+ Open protocol
+ Expand
3

Evaluating 3D Spheroid Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two thousand HCC cells/well or 1500 CCA cells/well were seeded into polyHEMA-coated 96-well culture plates. Upon formation, spheroids were stimulated immediately (time 0) with recombinant human ANG-2 (rh-ANG-2) (623-AN, R&D Systems, Minneapolis, MN, USA) and/or recombinant human VEGF (rh-VEGF) (293-VE, R&D Systems) proteins at increasing doses (0, 50, 100, 200, 400, 800 ng/mL). After 48 h from stimulation, the 3D viability assay was performed by transferring the obtained spheroids to a blank 96-well plate without coating and then adding the endpoint CellTiter-Glo® 3D reagent (Promega, Milan, Italy) to induce the ATP release from spheroids, according to the manufacturer’s instructions. The luminescence signal was recorded after 30 minutes with the GloMax® bioluminescent reader (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!